Associate Professor, University of Wisconsin, United States
Dr. Mohun Ramratnam is a highly respected Associate Professor of Cardiovascular Medicine at the University of Wisconsin School of Medicine and Public Health. With deep expertise in interventional cardiology, he also serves as the Director of Interventional Cardiology at the William S. Middleton VA Hospital in Madison, WI. Known for his translational research and patient-centered care, Dr. Ramratnam brings a wealth of clinical and academic experience to the field of cardiovascular medicine. His journey spans multiple prestigious institutions, and he continues to shape future cardiologists through his teaching, research, and clinical leadership.
Publication Profile
Scopus
🎓 Education Background:
Dr. Ramratnam earned dual B.A. degrees in Business Economics from Brown University in 1999. He completed his M.D. at the Feinberg School of Medicine, Northwestern University in 2004. Following this, he pursued residency training in Internal Medicine at Johns Hopkins Hospital (2004–2007) and a Cardiology Fellowship at the University of Pittsburgh Medical Center (2008–2011). He further specialized through Interventional Cardiology fellowships and research training at UPMC from 2011 to 2013. He holds certifications in internal medicine, cardiovascular disease, nuclear cardiology, echocardiography, cardiac catheterization, ACLS, and BLS.
💼 Professional Experience:
Dr. Ramratnam began his career as a research assistant and associate before transitioning into medicine. He has held instructional and faculty positions at UPMC and later moved to the University of Wisconsin, where he served as Assistant Professor (2013–2021) and currently as Associate Professor. Since 2013, he has directed Interventional Cardiology services at the William S. Middleton VA Hospital. His professional memberships include the American Heart Association, American College of Cardiology, and Society for Cardiovascular Angiography and Interventions.
🏆 Awards and Honors:
He graduated Cum Laude from Phillips Academy Andover in 1995, earned Alpha Omega Alpha honors at Northwestern in 2004, and has received several prestigious research awards, including the Pittsburgh Young Investigator Award (1st Place Oral Presentation, 2012) and the BCVS Travel Award for Young Investigators. His educational and research excellence has been consistently recognized throughout his academic career.
🔬 Research Focus:
Dr. Ramratnam’s research is focused on cardioprotection and mitochondrial function in cardiovascular disease. He explores innovative mechanisms such as sulfonylurea receptor variants and the role of mitochondrial potassium channels (ROMK) in cardiomyopathy. His funded research includes VA CDA-2 Awards and pilot grants from NIH and UW-Madison. His work seeks to develop novel therapies that target mitochondrial pathways to reduce heart disease severity.
📝 Conclusion:
Blending clinical expertise with cutting-edge research, Dr. Mohun Ramratnam stands as a thought leader in interventional cardiology and cardiovascular research. With numerous peer-reviewed publications and a commitment to translational science, he continues to push the boundaries of heart disease treatment and prevention, contributing meaningfully to academic medicine and public health.
📚 Top Publications
Transgenic knockdown of cardiac sodium/glucose cotransporter 1 attenuates PRKAG2 cardiomyopathy…
Journal of the American Heart Association, 2014
Cited by 100+ articles
Key discovery linking SGLT1 modulation to cardiac function.
Gene-Targeted Mice with the Human Troponin T R141W Mutation Develop Dilated Cardiomyopathy…
PLoS ONE, 2016
Cited by 60+ articles
Studied mutation impact on cardiomyopathy and calcium signaling.
Transgenic overexpression of the SUR2A-55 splice variant in mouse heart…
Heliyon, 2018
Cited by 50+ articles
Important in demonstrating mitochondrial protective mechanisms.
Cardiac-specific deletion of the sulfonylurea receptor 2 enhances glucose uptake…
JACC: Basic to Translational Science, 2019
Cited by 70+ articles
Showed that deletion of SUR2 can be cardioprotective.
Identification of Intrastent Pathology Associated with Late Stent Thrombosis Using OCT
Journal of Interventional Cardiology, 2015
Cited by 80+ articles
Applied optical coherence tomography to identify stent complications.